Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
46%
Odds Ratio
46%
Clinical Trial
34%
Uterine Cancer
34%
Hormone Therapy
31%
Health Care Cost
30%
Cross Sectional Study
27%
COVID-19
26%
Colonoscopy
25%
Colorectal Cancer Screening
24%
Medicare
23%
Aromatase Inhibitor
22%
Oncology
19%
Health Care
19%
Awareness
18%
Diseases
18%
Intestine Preparation
17%
Skin Cancer Prevention
17%
Ovarian Cancer
17%
Decision Making
17%
Cancer Risk
17%
Neoplasm
16%
Skin Cancer
16%
Metastatic Breast Cancer
14%
Prevalence
13%
Public Health
12%
Hormone Receptor
12%
Patient Compliance
12%
End of Life Care
11%
College Student
11%
Neoadjuvant Chemotherapy
11%
Genetic Screening
11%
Comorbidity
11%
Oncologist
11%
Colorectal Carcinoma
10%
Recurrent Disease
10%
Cytoreductive Surgery
10%
Sunscreen
10%
Cancer Therapy
10%
Adjuvant Chemotherapy
10%
Sun Protection
10%
Organ Donor
9%
Primary Health Care
9%
Melanoma
9%
Adenoma
9%
Occult Blood Test
9%
Hysterectomy
8%
Retrospective Cohort Study
8%
COVID-19 Vaccination
8%
Nursing and Health Professions
Breast Cancer
86%
Odds Ratio
39%
Malignant Neoplasm
34%
Hormonal Therapy
32%
Cross-Sectional Study
30%
Colonoscopy
29%
Diseases
27%
Confidence Interval
25%
Skin Cancer
24%
Intestine Preparation
23%
Genetic Screening
23%
Aromatase Inhibitor
21%
Cancer Therapy
20%
Metastatic Breast Cancer
20%
Content Analysis
14%
Health Care
13%
Adolescent
12%
Adjuvant Chemotherapy
12%
Medicare
11%
Cancer Chemotherapy
11%
College Student
11%
Terminal Care
11%
Cohort Analysis
10%
Hormone Receptor
9%
Patient Social Context
9%
Practice Guideline
9%
Adenoma
9%
Neoplasm
8%
Adjuvant Therapy
8%
Health Care Personnel
8%
Compliance
7%
Gastroenterologist
7%
Pandemic
7%
Patient Participation
7%
Medical Oncologist
7%
Cancer Adjuvant Therapy
7%
Recurrent Disease
7%
Cancer Prevention
6%
Prospective Cohort Study
6%
Patient Compliance
6%
Health Care Cost
6%
Adverse Event
5%
Electronic Medical Record
5%
Mental Health
5%
Interrater Reliability
5%
Cyclophosphamide Plus Doxorubicin Plus Etoposide Plus Prednisolone Plus Vincristine
5%
Cancer Screening
5%
Prevention and Control
5%
Survival Time
5%
Institutional Review
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
47%
Chemotherapy
32%
Malignant Neoplasm
28%
Diseases
21%
Aromatase Inhibitor
21%
Ovary Cancer
17%
Clinical Trial
17%
Colon Carcinoma
17%
Hormone Cancer Therapy
13%
Cross-Sectional Study
12%
Skin Cancer
12%
Coronavirinae
11%
Colorectal Carcinoma
11%
Uterus Cancer
11%
Recurrent Disease
10%
Sunscreen
9%
Cohort Study
7%
Endocrine Therapy
7%
Comorbidity
7%
SARS Coronavirus
6%
Folinic Acid
6%
Fluorouracil
6%
Hormone Receptor
6%
Endometrium Cancer
6%
Oxaliplatin
6%
Irinotecan
6%
Cyclophosphamide Plus Doxorubicin Plus Etoposide Plus Prednisolone Plus Vincristine
5%
Pandemic
5%
Prospective Cohort Study
5%
Fluoride
5%
Cancer Chemotherapy
5%
Infection
5%
Venous Thromboembolism
5%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
5%
Bisphosphonic Acid Derivative
5%
Anastrozole
5%
Hematologic Malignancy
5%
Chemoradiation Therapy
5%
Multiple Myeloma
5%
Bevacizumab
5%